Human topical treatment study · n=36
Efficacy and Safety of a Topical Nicotinamide Adenine Dinucleotide Skinbooster for the Treatment of Melasma.
Aesthetic plastic surgery · 2026
Explore connectionsWhat was studied
Prospective 21-week cohort, five microneedling sessions followed by sterile Sihler N NAD+ booster, three-week intervals.
Checked against the published abstract on Oct 1, 2026. Read the source ↗
Source text
Read the authors' abstract at the linked primary source.
Linked ingredients